Literature DB >> 24196284

Diversity of neuronal inhibition: a path to novel treatments for neuropsychiatric disorders.

Rebecca S Benham1, Elif Engin1, Uwe Rudolph1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24196284      PMCID： PMC3997169          DOI： 10.1001/jamapsychiatry.2013.3059

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  10 in total

1.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

2.  A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.

Authors:  B K Yee; R Keist; L von Boehmer; R Studer; D Benke; N Hagenbuch; Y Dong; R C Malenka; J-M Fritschy; H Bluethmann; J Feldon; H Möhler; U Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

Review 3.  Cortical inhibitory neurons and schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; David W Volk
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

Review 4.  Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.

Authors:  Uwe Rudolph; Frédéric Knoflach
Journal:  Nat Rev Drug Discov       Date:  2011-07-29       Impact factor: 84.694

5.  Neural bases for addictive properties of benzodiazepines.

Authors:  Kelly R Tan; Matthew Brown; Gwenaël Labouèbe; Cédric Yvon; Cyril Creton; Jean-Marc Fritschy; Uwe Rudolph; Christian Lüscher
Journal:  Nature       Date:  2010-02-11       Impact factor: 49.962

Review 6.  International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.

Authors:  Richard W Olsen; Werner Sieghart
Journal:  Pharmacol Rev       Date:  2008-09-12       Impact factor: 25.468

7.  Benzodiazepines as antidepressants: does GABA play a role in depression?

Authors:  F Petty; M H Trivedi; M Fulton; A J Rush
Journal:  Biol Psychiatry       Date:  1995-11-01       Impact factor: 13.382

Review 8.  α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.

Authors:  Elif Engin; Jing Liu; Uwe Rudolph
Journal:  Pharmacol Ther       Date:  2012-08-18       Impact factor: 12.310

9.  mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism.

Authors:  S Hossein Fatemi; Teri J Reutiman; Timothy D Folsom; Robert J Rooney; Diven H Patel; Paul D Thuras
Journal:  J Autism Dev Disord       Date:  2010-06

10.  Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.

Authors:  Sung Han; Chao Tai; Ruth E Westenbroek; Frank H Yu; Christine S Cheah; Gregory B Potter; John L Rubenstein; Todd Scheuer; Horacio O de la Iglesia; William A Catterall
Journal:  Nature       Date:  2012-08-22       Impact factor: 49.962
  10 in total
  5 in total

1.  Delays in GABAergic interneuron development and behavioral inhibition after prenatal stress.

Authors:  Stephanie J Lussier; Hanna E Stevens
Journal:  Dev Neurobiol       Date:  2016-01-22       Impact factor: 3.964

Review 2.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 3.  Inhibition in the amygdala anxiety circuitry.

Authors:  Olga Babaev; Carolina Piletti Chatain; Dilja Krueger-Burg
Journal:  Exp Mol Med       Date:  2018-04-09       Impact factor: 8.718

4.  Analyzing the mechanisms that facilitate the subtype-specific assembly of γ-aminobutyric acid type A receptors.

Authors:  Catherine Choi; Joshua L Smalley; Abigail H S Lemons; Qiu Ren; Christopher E Bope; Jake S Dengler; Paul A Davies; Stephen J Moss
Journal:  Front Mol Neurosci       Date:  2022-10-03       Impact factor: 6.261

Review 5.  Rho GTPases in the Amygdala-A Switch for Fears?

Authors:  Tasnuva Sarowar; Andreas M Grabrucker
Journal:  Cells       Date:  2020-08-26       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.